1072 related articles for article (PubMed ID: 34516275)
21. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
[TBL] [Abstract][Full Text] [Related]
22. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
Chun JY; Jeong H; Kim Y
J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
[TBL] [Abstract][Full Text] [Related]
23. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults.
Fisher KA; Bloomstone SJ; Walder J; Crawford S; Fouayzi H; Mazor KM
Ann Intern Med; 2020 Dec; 173(12):964-973. PubMed ID: 32886525
[TBL] [Abstract][Full Text] [Related]
24. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
COVID-19 National Preparedness Collaborators
Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020.
Bixler D; Miller AD; Mattison CP; Taylor B; Komatsu K; Peterson Pompa X; Moon S; Karmarkar E; Liu CY; Openshaw JJ; Plotzker RE; Rosen HE; Alden N; Kawasaki B; Siniscalchi A; Leapley A; Drenzek C; Tobin-D'Angelo M; Kauerauf J; Reid H; Hawkins E; White K; Ahmed F; Hand J; Richardson G; Sokol T; Eckel S; Collins J; Holzbauer S; Kollmann L; Larson L; Schiffman E; Kittle TS; Hertin K; Kraushaar V; Raman D; LeGarde V; Kinsinger L; Peek-Bullock M; Lifshitz J; Ojo M; Arciuolo RJ; Davidson A; Huynh M; Lash MK; Latash J; Lee EH; Li L; McGibbon E; McIntosh-Beckles N; Pouchet R; Ramachandran JS; Reilly KH; Dufort E; Pulver W; Zamcheck A; Wilson E; de Fijter S; Naqvi O; Nalluswami K; Waller K; Bell LJ; Burch AK; Radcliffe R; Fiscus MD; Lewis A; Kolsin J; Pont S; Salinas A; Sanders K; Barbeau B; Althomsons S; Atti S; Brown JS; Chang A; Clarke KR; Datta SD; Iskander J; Leitgeb B; Pindyck T; Priyamvada L; Reagan-Steiner S; Scott NA; Viens LJ; Zhong J; Koumans EH;
MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(37):1324-1329. PubMed ID: 32941417
[TBL] [Abstract][Full Text] [Related]
26. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
[TBL] [Abstract][Full Text] [Related]
27. Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States-January-July, 2021.
Kugeler KJ; Williamson J; Curns AT; Healy JM; Nolen LD; Clark TA; Martin SW; Fischer M
PLoS One; 2022; 17(3):e0264179. PubMed ID: 35263352
[TBL] [Abstract][Full Text] [Related]
28. Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
McDermott A
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011611
[No Abstract] [Full Text] [Related]
29. Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United States.
Griffin I; King J; Lyons BC; Singleton AL; Deng X; Bruce BB; Griffin PM
Emerg Infect Dis; 2024 Jun; 30(6):1144-1153. PubMed ID: 38781926
[TBL] [Abstract][Full Text] [Related]
30. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
31. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
Front Public Health; 2021; 9():709369. PubMed ID: 34368071
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.
Torres-Ibarra L; Basto-Abreu A; Carnalla M; Torres-Alvarez R; Reyes-Sanchez F; Hernández-Ávila JE; Palacio-Mejia LS; Alpuche-Aranda C; Shamah-Levy T; Rivera JA; Barrientos-Gutierrez T
Int J Epidemiol; 2022 May; 51(2):429-439. PubMed ID: 35157072
[TBL] [Abstract][Full Text] [Related]
33. Overcoming COVID-19 in West African countries: is herd immunity an option?
Ilesanmi OS; Akande A; Afolabi AA
Pan Afr Med J; 2020; 35(Suppl 2):103. PubMed ID: 33282058
[TBL] [Abstract][Full Text] [Related]
34. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
National Immunization Advisory Committee Technical Working Group
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
[TBL] [Abstract][Full Text] [Related]
35. United States COVID-19 Vaccination Preferences (CVP): 2020 Hindsight.
Craig BM
Patient; 2021 May; 14(3):309-318. PubMed ID: 33783724
[TBL] [Abstract][Full Text] [Related]
36. Simulated Identification of Silent COVID-19 Infections Among Children and Estimated Future Infection Rates With Vaccination.
Moghadas SM; Fitzpatrick MC; Shoukat A; Zhang K; Galvani AP
JAMA Netw Open; 2021 Apr; 4(4):e217097. PubMed ID: 33890990
[TBL] [Abstract][Full Text] [Related]
37. Individual preferences for COVID-19 vaccination in China.
Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
[TBL] [Abstract][Full Text] [Related]
38. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
[TBL] [Abstract][Full Text] [Related]
39. Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021.
Paltiel AD; Schwartz JL
Ann Intern Med; 2021 Nov; 174(11):1563-1571. PubMed ID: 34461034
[TBL] [Abstract][Full Text] [Related]
40. Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.
Skowronski DM; Kaweski SE; Irvine MA; Chuang ESY; Kim S; Sabaiduc S; Reyes RC; Henry B; Sekirov I; Smolina K
CMAJ; 2023 Oct; 195(42):E1427-E1439. PubMed ID: 37903524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
